206 related articles for article (PubMed ID: 32689603)
1. The disease presentation of Moyamoya angiopathy in Eastern India.
Das S; Dubey S; Acharya M; Ghosh R; Chatterjee S; Hazra A; Lahiri D; Segupta S; Chatterjee S; Das G; Sarkar N; Ray BK; Kraemer M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104957. PubMed ID: 32689603
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Moyamoya Angiopathy in Eastern India.
Das S; Dubey S; Das S; Hazra A; Pandit A; Ghosh R; Ray BK
Front Neurol; 2022; 13():837704. PubMed ID: 35309562
[TBL] [Abstract][Full Text] [Related]
3. Profile of precipitating factors and its implication in 160 Indian patients with Moyamoya angiopathy.
Das S; Ray BK; Pandit A; Ghosh R; Diehl R; Dubey S; Kraemer M
J Neurol; 2023 Mar; 270(3):1654-1661. PubMed ID: 36477636
[TBL] [Abstract][Full Text] [Related]
4. Adult moyamoya angiopathy in Bourgogne-Franche-Comté: Epidemiology, diagnosis and management.
Brandicourt P; Blanc C; Bonnet L; Béjot Y; Ricolfi F; Drouet C; Moulin T; Thines L
Rev Neurol (Paris); 2019 Apr; 175(4):247-251. PubMed ID: 30447881
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation of Moyamoya angiopathy in Europeans: experiences from Germany with 200 patients.
Kraemer M; Schwitalla JC; Diesner F; Aktas O; Hartung HP; Berlit P
J Neurol; 2019 Jun; 266(6):1421-1428. PubMed ID: 30868219
[TBL] [Abstract][Full Text] [Related]
6. "Asymptomatic" Moyamoya Angiopathy: Is it Truly Asymptomatic?
Das S; Ray BK; Ghosh R; Dubey S
J Stroke Cerebrovasc Dis; 2022 Jun; 31(6):106432. PubMed ID: 35367845
[TBL] [Abstract][Full Text] [Related]
7. Impact of COVID-19 pandemic in natural course of Moyamoya Angiopathy: an experience from tertiary-care-center in India.
Das S; Ray BK; Ghosh R; Sengupta S; Pandit A; Dubey S
Egypt J Neurol Psychiatr Neurosurg; 2021; 57(1):166. PubMed ID: 34924748
[TBL] [Abstract][Full Text] [Related]
8. Down syndrome and moyamoya: clinical presentation and surgical management.
See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
[TBL] [Abstract][Full Text] [Related]
9. Moyamoya: Indiana University Medical Center experience.
Yilmaz EY; Pritz MB; Bruno A; Lopez-Yunez A; Biller J
Arch Neurol; 2001 Aug; 58(8):1274-8. PubMed ID: 11493168
[TBL] [Abstract][Full Text] [Related]
10. Thalassemia and Moyamoya Syndrome: Epidemiology and long-term outcome.
Das S; Ray BK; Pandit A; Ghosh R; Chakraborty AP; Dubey S
Eur J Paediatr Neurol; 2022 Nov; 41():63-70. PubMed ID: 36368232
[TBL] [Abstract][Full Text] [Related]
11. Misdiagnoses and delay of diagnoses in Moyamoya angiopathy-a large Caucasian case series.
Graf J; Schwitalla JC; Albrecht P; Veltkamp R; Berlit P; Hartung HP; Aktas O; Kraemer M
J Neurol; 2019 May; 266(5):1153-1159. PubMed ID: 30805794
[TBL] [Abstract][Full Text] [Related]
12. Patterns of cerebral ischemia in children with moyamoya.
Rafay MF; Armstrong D; Dirks P; MacGregor DL; deVeber G
Pediatr Neurol; 2015 Jan; 52(1):65-72. PubMed ID: 25459363
[TBL] [Abstract][Full Text] [Related]
13. Moyamoya Angiopathy: An Underdiagnosed Cause of Ischemic Stroke in a Tunisian Pediatric Cohort.
Bouchaala W; Laroussi S; Mzid Y; Maaloul I; Jallouli O; Zouari S; Ben Nsir S; Mnif Z; Kammoun F; Triki C
Pediatr Neurol; 2024 Jan; 150():3-9. PubMed ID: 37925769
[TBL] [Abstract][Full Text] [Related]
14. Disparities in the symptomatic presentation of Moyamoya disease in the United States: A nationwide all-payer analysis.
Fuentes AM; Chiu RG; Mehta AI
J Clin Neurosci; 2021 May; 87():92-96. PubMed ID: 33863543
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological and clinical features of moyamoya disease in the USA.
Kainth D; Chaudhry SA; Kainth H; Suri FK; Qureshi AI
Neuroepidemiology; 2013; 40(4):282-7. PubMed ID: 23445954
[TBL] [Abstract][Full Text] [Related]
16. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
[TBL] [Abstract][Full Text] [Related]
17. Moyamoya vasculopathy - Patient demographics and characteristics in the Finnish population.
Saarela M; Mustanoja S; Pekkola J; Tyni T; Hernesniemi J; Kivipelto L; Tatlisumak T
Int J Stroke; 2017 Jan; 12(1):90-95. PubMed ID: 27625049
[TBL] [Abstract][Full Text] [Related]
18. Moyamoya angiopathy: long-term follow-up study in a Finnish population.
Savolainen M; Mustanoja S; Pekkola J; Tyni T; Uusitalo AM; Ruotsalainen S; Poutiainen E; Hernesniemi J; Kivipelto L; Tatlisumak T
J Neurol; 2019 Mar; 266(3):574-581. PubMed ID: 30560456
[TBL] [Abstract][Full Text] [Related]
19. Limb-shaking TIA in Moyamoya angiopathy.
Das S; Ghosh R; Dubey S; Pandit A; Ray BK; Kraemer M
Clin Neurol Neurosurg; 2021 Aug; 207():106783. PubMed ID: 34225004
[TBL] [Abstract][Full Text] [Related]
20. Nationwide survey on quasi-moyamoya disease in Japan.
Hayashi K; Horie N; Izumo T; Nagata I
Acta Neurochir (Wien); 2014 May; 156(5):935-40. PubMed ID: 24499994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
